Condition
Retinal Detachment
ClinicalTrials.gov condition label
Clinical trials
15 shownProteomic Biomarker Identification in Age-Related Macular Degeneration, Diabetic Retinopathy and Retinal DetachmentNCT07500324 · 2024-01-24
RECRUITINGHigh Resolution, High-speed Multimodal Ophthalmic ImagingNCT04129021 · 2019-07-03
RECRUITINGIntraoperative OCT Guidance of Intraocular Surgery IINCT03713268 · 2018-09-30
RECRUITINGEffect of Intraocular Tamponade on Visual PerceptionNCT05543018 · 2022-09-12
UNKNOWNHigh Resolution Optical Coherence TomographyNCT05130385 · 2021-11-30
UNKNOWNComputer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus PhotographNCT04723160 · 2020-08-10
COMPLETEDBimodal and Coaxial High Resolution Ophtalmic ImagingNCT04620876 · 2019-10-01
UNKNOWNFeasibility Study and Preliminary Application Study on Iris OCTANCT03631108 · 2018-10-01
UNKNOWNSilicone Oil Versus Gas in PDR Patients Undergoing VitrectomyNCT03660384 · 2018-09-04
COMPLETEDEvaluation of Discomfort Associated With Scleral Depression During Retina ExaminationsNCT04115917 · 2018-01-01
COMPLETEDComparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal DetachmentsNCT01255293 · 2010-11-01
COMPLETEDAvastin for PDR (Proliferative Diabetic Retinopathy)NCT01270542 · 2009-06-01
COMPLETEDRanibizumab for Diabetic Traction Retinal DetachmentNCT01201161 · 2008-12-01
COMPLETEDPars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA)NCT00690768 · 2008-03-01
COMPLETEDDiabetic Retinopathy Vitrectomy Study (DRVS)NCT00000154 · 1976-10-01
COMPLETEDCommon interventions
Sham injectionOTHER21000 centistoke silicone oilPROCEDURE15000 centistoke silicone oilPROCEDURE1Avastin (bevacizumab)DRUG1BevacizumabDRUG1Bimodal high resolution imaging of the retinaOTHER1Biological Sample CollectionDEVICE1Cotton tipped applicatorDEVICE1ElectroretinogramDIAGNOSTIC_TEST1High-resolution optical coherence tomography (High-Res-OCT)DEVICE1High-resolution retinal imaging through adaptive opticsDEVICE1High-resolution retinal imaging through holographic systemsDEVICE1Microscope integrated optical coherence tomographyDEVICE1OCTA (ZEISS)DIAGNOSTIC_TEST1pars plana vitrectomyPROCEDURE1PPV/C3F8PROCEDURE1PPV/SOPROCEDURE1RanibizumabDRUG1Schocket scleral depressorDEVICE1Software assisted imaging diagnosisDIAGNOSTIC_TEST1Standard spectral domain OCT (SD-OCT)DEVICE1VitrectomyPROCEDURE1Vitrectomy operationPROCEDURE1
Leading sponsors
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts2University of Sao Paulo2Benha University1Duke University1Fondazione G.B. Bietti, IRCCS1Insel Gruppe AG, University Hospital Bern1Mid Atlantic Retina1National Eye Institute (NEI)1New York City Health and Hospitals Corporation1Rush Eye Associates1Shanghai Eye Disease Prevention and Treatment Center1University of Southern California1Visionary Intelligence Ltd.1
Trial status mix
COMPLETED8
UNKNOWN4
RECRUITING3
Phase mix
NA8
PHASE22
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.